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Silver nanoparticles (AgNPs) have been used as antibacterial, antifungal, antiviral, anti-inflammtory, and antiangiogenic
due to its unique properties such as physical, chemical, and biological properties. The present study was aimed to
investigate antibacterial and anti-biofilm activities of silver nanoparticles alone and in combination with conventional
antibiotics against various human pathogenic bacteria. Here, we show that a simple, reliable, cost effective and green
method for the synthesis of AgNPs by treating silver ions with leaf extract of Allophylus cobbe. The A. cobbe-mediated
synthesis of AgNPs (AgNPs) was characterized by ultraviolet-visible absorption spectroscopy, X-ray diffraction (XRD),
Fourier transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), dynamic light scattering (DLS),
and transmission electron microscopy (TEM). Furthermore, the antibacterial and anti-biofilm activity of antibiotics or
AgNPs, or combinations of AgNPs with an antibiotic was evaluated using a series of assays: such as in vitro killing assay,
disc diffusion assay, biofilm inhibition, and reactive oxygen species generation in Pseudomonas aeruginosa, Shigella
flexneri, Staphylococcus aureus, and Streptococcus pneumonia. The results suggest that, in combination with antibiotics,
there were significant antimicrobial and anti-biofilm effects at lowest concentration of AgNPs using a novel plant
extract of A. cobbe, otherwise sublethal concentrations of the antibiotics. The significant enhancing effects were
observed for ampicillin and vancomycin against Gram-negative and Gram-positive bacteria, respectively. These data
suggest that combining antibiotics and biogenic AgNPs can be used therapeutically for the treatment of infectious
diseases caused by bacteria. This study presented evidence of antibacterial and anti-biofilm effects of A. cobbe-mediated
synthesis of AgNPs and their enhanced capacity against various human pathogenic bacteria. These results suggest that
AgNPs could be used as an adjuvant for the treatment of infectious diseases.
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Nanotechnology is a promising field for generating new
types of nanomaterials with biomedical applications [1].
Silver nanoparticles (AgNPs) have attracted significant
interest among the emerging nanoproducts because of
their unique properties and increasing use for various
applications in nanomedicine. Silver, in the form of silver
nitrate or silver sulfadiazine, has been long used for the
treatment of bacterial infections associated with burns
and wounds because of its antibacterial properties [2].* Correspondence: gsangiliyandi@yahoo.com; jhkim541@konkuk.ac.kr
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reproduction in any medium, provided the origNumerous physical, chemical, and biological methods
have been developed for the synthesis of AgNPs. How-
ever, the synthesis of nanoparticles using conventional
physical and chemical methods has a low yield, and it is
difficult to prepare AgNPs with a well-defined size [3].
Furthermore, chemical methods make use of toxic-
reducing agents, such as citrate, borohydride, or other
organic compounds, and can negatively impact the en-
vironment. Because the control of particle size and
shape is an important factor for various biomedical ap-
plications, the use of biological methods to synthesize
AgNPs is an environmentally friendly alternative. These
methods involve synthesizing AgNPs using bacterial pro-
teins that can exert control over the shape, size, andis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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ters such as the type of microorganism, growth stage,
growth medium, synthesis conditions, pH, substrate con-
centrations, temperature, and reaction time [4].
The conventional methods like physical and chemical
such as laser ablation, pyrolysis, lithography, chemical
vapour deposition, sol-gel techniques, and electro-
deposition for synthesis of nanoparticles seem to be very
expensive and hazardous. Further, the procedure involves
various reactants, in particularly reducing agents (eg., so-
dium borohydride or potassium bitartrate or methoxypo-
lyethylene glycol or hydrazine) and also it requires a
stabilizing agent such as sodium dodecyl benzyl sulfate or
polyvinyl pyrrolidone to prevent the agglomeration of me-
tallic nanoparticles. Although many methods are available
for the synthesis of nanoparticles, there is an increasing
need to develop simple, cost effective, high-yield, and en-
vironmentally friendly procedures. Therefore, it is essen-
tial to look for alternative green methods for the synthesis
of metal nanoparticles [4,5]. In biological methods, a vast
array of biological resources easily available in nature in-
cluding plants and plant products, algae, fungi, yeast, bac-
teria, and viruses could all be employed for synthesis of
nanoparticles, and the time required for complete reduc-
tion is lesser. Synthesized AgNPs are readily available in
solution with high density and are stable. Among several
natural sources, plant and plant products are available eas-
ily, and it facilitates synthesis of nanoparticles fairly rap-
idly. In addition, leaf extracts contain alkaloids, tannin,
steroids, phenol, saponins, and flavonoids in aqueous ex-
tracts. On the basis of these compounds found in the ex-
tracts, we expect that the proteins or polysaccharides or
secondary metabolites of leaf extracts can reduce the Ag+
ions to Ag0 state and form silver nanoparticles. In recent
years, various plants have been explored for synthesis of
silver and gold nanoparticles. Recently, Singhal et al. [6]
synthesized silver nanoparticles using Ocimum sanctum
leaf extract showed significant antibacterial activity against
E. coli and Staphylococcus aureus. Although several stud-
ies have reported the antibacterial activity of silver nano-
particles, the combination of silver nanoparticles and
antibiotics studies are warranted.
The increasing prevalence of microbial resistance has
made the management of public health an important
issue in the modern world. Although several new antibi-
otics were developed in the last few decades, none have
improved activity against multidrug-resistant bacteria
[7]. Therefore, it is important to develop alternate and
more effective therapeutic strategies to treat Gram-
negative and Gram-positive pathogens. Nanoparticles,
which have been used successfully for the delivery of
therapeutic agents [8], in diagnostics for chronic diseases
[9], and treatment of bacterial infections in skin and
burn wounds, are one option [10].AgNPs possess antibacterial [11,12], anti-fungal [13],
anti-inflammatory [14], anti-viral [15], anti-angiogenic
[16], and anti-cancer activities [17,18]. Developing AgNPs
as a new generation of antimicrobial agents may be an
attractive and cost-effective means to overcome the drug
resistance problem seen with Gram-negative and Gram-
positive bacteria. The first aim of the present study was to
develop a simple and environmentally friendly approach
for the synthesis and characterization of AgNPs using
Allophylus cobbe. The second aim of this study involved
systematically analyzing the antibacterial and anti-biofilm
activities of the biologically prepared AgNPs against a
panel of human pathogens, including Pseudomonas
aeruginosa, Shigella flexneri, Staphylococcus aureus, and
Streptococcus pneumoniae. The effects of combining anti-
biotics with AgNPs against Gram-negative and Gram-
positive bacteria were also investigated.
Methods
Bacterial strains and reagents
Mueller Hinton broth (MHB) or Mueller Hinton agar
(MHA), silver nitrate and ampicillin, chloramphenicol,
erythromycin, gentamicin, tetracycline, and vancomycin
antibiotics were purchased from Sigma-Aldrich (St.
Louis, MO, USA). All other chemicals were purchased
from Sigma-Aldrich unless otherwise stated. All culture
media and chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise stated.
The strains of P. aeruginosa, S. flexneri, S. aureus, and S.
pneumoniae used in the present study were obtained
from our culture collection.
Synthesis and characterization of AgNPs
Allophylus cobbe leaves were collected from plants grow-
ing in the hills of the Ooty region of India, and stored at
4°C until needed. Twenty grams of A. cobbe leaves were
washed thoroughly with double-distilled water and then
sliced into fine pieces, approximately 1 to 5 cm [2],
using a sharp stainless steel knife. The finely cut A.
cobbe leaves were suspended in 100 ml of sterile distilled
water and then boiled for 5 min. The resulting mixture
was filtered through Whatman filter paper no. 1. The fil-
tered extract was used for the synthesis of AgNPs by
adding 10 to 100 ml of 5 mM AgNO3 in an aqueous solu-
tion and incubated for 6 h at 60°C at pH 8.0. The bioreduc-
tion of the silver ions was monitored spectrophotometrically
at 420 nm.
Characetrization of AgNPs
The synthesized particles were characterized according
to methods described previously [4]. The size distribu-
tion of the dispersed particles was measured using a
Zetasizer Nano ZS90 (Malvern Instruments Limited,
Malvern, WR, UK). The synthesized AgNPs were freeze
Table 2 Determination of sub-lethal value of antibiotics
and AgNPs
Bacterial species Amp Chl Ery Gen Tet Van AgNPs
P. aeruginosa 0.2 0.4 0.2 0.2 0.3 0.6 0.15
S. flexneri 0.2 0.4 0.2 0.2 0.3 0.6 0.15
S. aureus 0.4 0.8 0.4 0.4 0.6 0.4 2.0
S. pneumoniae 0.4 0.8 0.4 0.4 0.6 0.4 2.0
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were evaluated using an X-ray diffractometer (PHILIPS
X'Pert-MPD diffractometer, Amsterdam, the Netherlands)
and Cu-Kα radiation 1.5405 Å over an angular range of
10° to 80°, at a 40 kV voltage and a 30-mA current. The
dried powder was diluted with potassium bromide in the
ratio of 1:100 and recorded the Fourier transform infrared
spectroscopy (FTIR) (PerkinElmer Inc., Waltham, MA,
USA) and spectrum GX spectrometry within the range of
500 to 4,000 cm−1. The size distribution of the dispersed
particles was measured using a Zetasizer Nano ZS90
(Malvern Instruments Limited, UK). Transmission elec-
tron microscopy (TEM, JEM-1200EX) was used to deter-
mine the size and morphology of AgNPs. AgNPs were
prepared by dropping a small amount of aqueous disper-
sion on copper grids, dried and examined in the trans-
mission electron microscope. XPS measurements were
carried out in a PHI 5400 instrument with a 200 W Mg
Kα probe beam.
Determination of minimum inhibitory concentrations of
AgNPs and antibiotics
To determine the minimum inhibitory concentrations
(MICs) of AgNPs or antibiotics, bacterial strains were
cultured in Mueller Hinton Broth (MHB). Cell suspen-
sions were adjusted to obtain standardized populations
by measuring the turbidity with a spectrophotometer
(DU530; Beckman; Fullerton, CA, USA). Susceptibility
tests were performed by twofold microdilution of the anti-
biotics and AgNPs in standard broth following the Clinical
and Laboratory Standards Institute (CLSI) guidelines [19].
The bacterial strains, at mid-log phase (1 × 106/ml), were
inoculated into MHB, and 0.1 ml was dispensed per well
into a 96-well microtiter plate. P. aeruginosa, S. flexneri, S.
aureus, and S. pneumoniae were then exposed to different
concentrations of AgNPs or antibiotics. Growth was
assayed using a microtiter enzyme-linked immunosorbent
assay (ELISA) reader (Emax; Molecular Devices; Sunnyvale,
CA, USA) by monitoring absorbance at 600 nm. The
MICs of AgNPs and antibiotics (Table 1) were determined
as the lowest concentrations that inhibited visible growth
of the bacteria. Antibiotic or AgNP concentrations that re-
duced the number of susceptible cells by less than 20%
after 24 h of incubation were designated as ‘sub-lethal’
(Table 2). Viability assays were carried out with differentTable 1 Determination of MIC value of antibiotics and
AgNPs
Bacterial species Amp Chl Ery Gen Tet Van AgNPs
P. aeruginosa 1.0 2.0 1.0 1.0 1.5 3.0 0.59
S. flexneri 1.0 2.0 1.0 1.0 1.5 3.0 0.60
S. aureus 2.0 4.0 2.0 2.0 3.0 2.0 0.75
S. pneumoniae 2.0 4.0 2.0 2.0 3.0 2.0 0.76concentrations of antibiotics or AgNPs alone, or with
combinations of sub-lethal concentrations of antibiotics
and AgNPs.
Disc diffusion assay
The agar diffusion assay was performed as described
previously using Mueller Hinton agar [7,12,20]. Conven-
tional and broad spectrum antibiotics were selected to
assess the effect of combined treatment with antibiotics
and AgNPs. Based on the CLSI standard, the concentra-
tions of antibiotics used were ampicillin (10 μg/ml),
chloramphenicol (30 μg/ml), erythromycin (15 μg/ml),
gentamicin (10 μg/ml), tetracycline (30 μg/ml), and
vancomycin (30 μg/ml). Each standard paper disc was
further impregnated with the MIC of AgNPs for each
bacterial strain when determining the effects of combin-
ation treatments. A single colony of each test strain was
grown overnight in MHB on a rotary shaker (200 rpm)
at 37°C. The inocula were prepared by diluting the over-
night cultures with 0.9% NaCl to a 0.5 McFarland stand-
ard. Inocula were applied to the plates along with the
control and treated discs containing different antibiotics.
Similar experiments were carried out with AgNPs alone.
After incubation at 37°C for 24 h, a zone of inhibition
(ZOI) was measured by subtracting the disc diameter
from the diameter of the total inhibition zone. The as-
says were performed in triplicate. Antibacterial activity
was quantified by the equation (B − A)/A × 100, where A
and B are the ZOIs for antibiotic and antibiotic with
AgNPs, respectively [20].
In vitro killing assay
The in vitro killing assay was performed as described
previously with some modifications [21]. Cells were
grown overnight in MHB at 37°C and then regrown in
fresh medium for 4 h before being collected by centrifu-
gation and suspended in deionized water. A cell suspen-
sion consisting of 106 cells/ml was incubated with
various concentrations of antibiotics or AgNPs, or com-
binations of AgNPs with an antibiotic for 4 h at 37°C.
After incubation, bacteria were harvested at the indi-
cated time points and 100-μl aliquots were taken from
each sample to determine the number of colony-forming
units (CFUs). Experiments were performed with various
controls including a positive control (AgNPs and MHB,
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oculum, without AgNPs). All samples were plated in
triplicate and values were averaged from three inde-
pendent experiments. The experiments with sublethal
concentrations of antibiotics or AgNPs, or combina-
tions of AgNPs and antibiotics, were performed for
4 h at 37°C.
Determination of biofilm activity using the tissue culture
plate method (TCP)
This assay was performed to determine the ability of
AgNPs to inhibit biofilm activity. The assay is based on
colorimetric measurements of the crystal violet incorpo-
rated by sessile cells [22,23]. Briefly, individual wells of
sterile, 96-well flat-bottom polystyrene TCPs were filled
with 180 μl of a single bacterial species (1 × 106/ml).
After culturing for 24 h, different concentrations of
AgNPs were added. The cell culture plates were then in-
cubated for 4 h at 37°C. For combination experiments,
bacteria were treated with sublethal concentrations of
antibiotics, or individual antibiotics in combination with
AgNPs. After incubation, the media were removed and
the wells were washed three times with 200 μl sterile
distilled water to remove non-adherent bacteria. The
wells were air dried for 45 min and 200 μl per well of a
0.1% (v/v) crystal violet solution in water were added for
45 min. The wells were then washed five times with
300 μl of sterile distilled water to remove excess stain.
The dye incorporated by the adherent cells was solubi-
lized with 200 μl of 95% (v/v) ethanol. The absorbance
of each well was measured at 595 nm using a microtiter
ELISA reader. The absorbance difference between treated
and control wells was considered as an index of bacterial
adherence to the surface and thus the activity of biofilms.
The percentage inhibition of biofilm activity was calcu-
lated using the following equation: [1 − (A595 of cells
treated with AgNPs/A595 of non-treated control cells)] ×
100 [24]. Experiments were performed in triplicate. The
data are expressed as means ± SD.
Measurement of reactive oxygen species (ROS) generation
An assay for superoxide anions was carried out according
to the manufacturer's instructions (In Vitro Toxicology
Assay Kit, (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfo-
phenyl)-5- [(phenylamino)-carbonyl]-2H-tetrazolium inner
salt (XTT) based, catalog number TOX2), was purchased
from Sigma-Aldrich, USA. All test strains were grown in
MHB. Cells were collected, washed with phosphate-
buffered saline (PBS), and resuspended in PBS at a con-
centration of 106 viable cells (determined as CFUs)/ml.
XTT was added to the cell suspension at a concentration
of 125 μM from a 7.5 mM stock solution in PBS. Cell sus-
pensions were incubated at 37°C on a rotary shaker for
12 h. Aliquots were then removed and spun in amicrofuge, and the absorption of the supernatant was
measured at 450 nm. The reduction of XTT in the ab-
sence of cells was determined as the control and sub-
tracted from the values obtained in the presence of cells.
Statistical analyses
All assays were carried out in triplicate and the experi-
ments were repeated at least three times. The results are
presented as means ± SD. All experimental data were
compared using the Student's t test. A p value less than
0.05 was considered statistically significant.
Results and discussion
Synthesis and characterization of AgNPs
Increasing antibiotic resistance is an inevitable conse-
quence of continuous antibiotic usage throughout the
world. With the emergence of new virulent pathogens, it
is essential to enhance our antibacterial arsenal [21,25].
Recently, there has been significant interest in anti-
bacterial nanoparticles as a means to overcome the
problem of drug resistance in various pathogenic mi-
croorganisms. Silver ions and salts are known for their
potent antimicrobial and anti-biofilm activities. How-
ever, although used as a therapeutic agent, silver ions
exhibit high toxicity and have relatively low stability
because they are easily inactivated by complexation
and precipitation with interfering salts [7,23]. To over-
come these limitations, we have used an extract of leaf
from the A. cobbe plant as an environmentally friendly,
simple, cost effective, and biocompatible method to
synthesize AgNPs.
The aim of this experiment was to produce smaller
sizes of AgNPs using A. cobbe leaf extract, which acts as
a reducing as well as stabilizing/capping agent. In order
to control the particle size of AgNPs, 5 mM AgNO3 was
added to the leaf extract and incubated for 6 h at 60°C
at pH 8.0. Synthesis was confirmed by visual observation
of the leaf extract and AgNO3. The mixture of leaf ex-
tract and AgNO3 showed a color change from green to
brown. No color change was observed during incubation
of leaf extract without AgNO3 (Figure 1). The appear-
ance of a brown color in AgNO3-treated leaf extract sug-
gested the formation of AgNPs (Gurunathan et al. [4,16];
Sathiya and Akilandeswari [26]).
Prior to the study of the cytotoxic effect of AgNPs,
characterization of AgNPs was performed according to
methods previously described [4]. The synthesized
AgNPs were characterized by UV-visible spectroscopy,
which has been shown to be a valuable and important
tool for the analysis of metal nanoparticles. In the UV-
visible spectrum, a strong, broad peak at about 420 nm
was observed for AgNPs (Figure 1). The specific and
characteristic features of this peak, assigned to a surface
plasmon, has been well documented for various metal
Figure 1 Characterization of AgNPs synthesized using A. cobbe leaf extracts. The absorption spectra of AgNPs exhibited a strong, broad
peak at 420 nm. This band was attributed to the surface plasmon resonance of the AgNPs. The images show the spectrum of AgNO3 (1), leaf
extract (2), and mixture of AgNO3 and leaf extract (3) at 6 h exposure. After exposure for 6 h, the color of the colloidal solution of AgNPs turned
from green to dark brown, indicating the formation of AgNPs.
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[27,28]. The silver nanoparticles were formed by adding
10 ml leaf extracts with aqueous AgNO3. After 6 h, the
color of the mixed solutions of leaf extract and AgNO3
changed from pale green to deep brown indicating the
formation of silver nanoparticles. The change in color of
the reaction medium as an effect of presence of reducing
potential substances present in the leaf extract. The
color of the silver nanoparticles are due to excitation of
surface plasmon vibration in silver nanoparticles and this
color change is due to redox reaction between the leaf
extract and AgNO3. AgNPs have free electrons, which
give rise to a surface plasmon resonance absorption due
to the combined vibration of electrons of the metal
nanoparticles in resonance with the light wave. [29] It is
observed from Figure 1 that the synthesized AgNPs dis-
play a clear and single surface plasmon resonance (SPR)
band located at 420 nm which confirms the reduction of
silver ion to metallic silver. In contrast, AgNO3 shows
maximum absorbtion at 220 nm, whereas the leaf ex-
tract shows two absorbtion peaks at 450 and 650 nm.
The sharp absorption peak of AgNPs indicates that the
formation of spherical and homogeneous distribution of
silver nanoparticles. The similar observation was re-
ported using leaf extract of Delonix elata mediated syn-
thesis of silver nanoparticles [26].XRD analysis of AgNPs
Further, the synthesized silver nanoparticles were con-
firmed using XRD analysis. Figure 2 shows that the XRD
patterns of natural dried silver nanoparticles synthesized
using leaf extract. A number of Bragg reflections with 2θ
values of 24.48°, 30.01°, 33.30°, 34.50°, 46.30° sets of lat-
tice planes are observed which may be indexed to the
(111), (200), and (220) faces of silver respectively. The
XRD pattern thus clearly illustrates that the silver nano-
particles formed in this present synthesis are crystalline
in nature and having face centered cubic (fcc) crystal
structure. The XRD pattern confirmed the presence of
Ag colloids in the sample. A strong diffraction peak lo-
cated at 30.01 was ascribed to the (111) facets of Ag.
The intensive diffraction peak at a 2θ value of 30.01°
from the (111) lattice plane of fcc silver unequivocally
indicates that the particles are made of pure silver. Two
additional broad bands are observed at 34.50°, 46.30°
correspond to the (200) and (220) planes of silver re-
spectively (Figure 2). The Braggs reflections were also
observed in the XRD pattern at 2θ = 24.48° and 32.50°.
The assigned peaks at 2θ values of 24.48°, 29.0°, and
32.50 (*), may be related to crystalline and amorphous
organic phase [26,30-33]. In the obtained spectra, the
Bragg peak position and their intensities were compared
with the standard JCPDS files. The result shows that the
Figure 2 XRD pattern of silver nanoparticles synthesized using A. cobbe leaf broth.
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nanoparticles was found to be 5 nm. The XRD pattern
thus clearly indicated that the AgNPs formed in the
present synthesis were crystalline in nature. Pasupuleti
et al. and other reserachers observed a similar XRD pat-
tern of silver nanoparticles using Rhinacanthus nasutus
leaf extract. Some unassigned peaks (*) have also been
observed suggesting that the crystallization of bio-
organic phase [26,30-33].
FTIR spectra of AgNPs
The FTIR spectra were recorded to identify potential
biomolecules that contributed to the reduction of the Ag+
ions and to the capping of the bioreduced AgNPs [33].
Figure 3A shows FTIR spectra of A. cobbe leaf extract ob-
served at 3,420 and 1,730 cm−1 are characteristic of the
O-H and C =O stretching modes for the OH and C =O
groups possibly secondary metabolites of leaf extract.
Figure 3B shows the FTIR spectra of purified silver nano-
particles, the presence of bonds due to O-H stretching
(around 3,441 cm−1), C =O group (around 1,636 cm−1),
the peak at 1,636 cm−1 could be assigned to the vibrations
due to amide I band present in the proteins and the peak
around 1,384 cm−1 assigned to geminal methyl group. The
minor band 1,054 cm−1 corresponds to C-N stretching al-
cohols, the band 594, and 887 cm−1 regions for C-H out
of plane bend, which are characteristics of aromatic phe-
nols [26]. The spectra also illustrate a prominent shift in
the wave numbers corresponding to amide I band
(1,636 cm−1) and amide II band (1520 cm−1) linkages, vali-
dates that free amino (−NH2) or carboxylate (−COO
−)
groups in compounds of the A. cobbe leaf extract have
interacted with AgNPs surface making AgNPs highly
stable. The energy at this vibration is sensitive to the sec-
ondary and tertiary structure of the proteins. The bandobserved at 3,441 cm−1 was characteristic of −NH stretch-
ing of the amide (II) band. Several bands between
2,000 cm−1 to 3,000 cm−1 were absent, which could be at-
tributed to protein precipitation occurring during the re-
duction and stabilization of the AgNPs [33]. We have
observed some additional peaks of silver nanoparticles lo-
cated at around 1,054 cm−1 can be assigned as the C-N
stretching vibrations of amine. This present result ob-
tained from A.cobbe agrees with those reported previously
for Rhinacanthus nasutus [33], Thevetia peruviana [34],
latex of Jatropha curcas [35]. Our observation lends sup-
port to a previous study in which formation of spherical
silver nanoparticles was reported by using various plant
extracts. Further, the FTIR patterns of A. cobbe-mediated
AgNPs prove to be powerful evidence in favor of the UV-
vis spectra and TEM images for the presence of silver
nanoparticles. Several studies have been shown that leaf
extracts are responsible for the reduction of silver ions for
the synthesis of silver nanoparticles. The absorption peak
at 1,636 cm−1 is close to that reported for native proteins
[36] which suggest that proteins are interacting with bio-
synthesized nanoparticles. It is well-known that proteins
can bind to gold nanoparticles either through free amine
groups or cysteine residues in the proteins [37]. A similar
mechanism could be possible, the leaf extract from A.
cobbe cap the silver nanoparticles, thereby stabilizing
them. Similar FTIR pattern was also observed for synthe-
sis of silver nanoparticles using Geranium leaf extract
[38], Ocimum sanctum leaf extract [6,26,39].
XPS analysis of AgNPs
X-ray photoelectron spectroscopy (XPS) was utilized to
investigate the chemical state of the leaf extract-mediated
synthesis of AgNPs. The quantitative Ag/C atomic ratios
of the samples were determined using the peak area ratio
Figure 3 FTIR spectra of A. cobbe leaf broth (A), silver nanoparticles synthesized by A. cobbe leaf broth (B).
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factor (SF) of each element in XPS. Figure 4 shows high-
resolution XPS spectra of the C(1 s) core level for the
AgNPs. The binding energies of Ag(3d5/2) and Ag(3d3/2)
peaks were found at binding energies of 368.0 and
374.0 eV, respectively. To further understand the chemical
state of the AgNPs on the surface, a detailed deconvolu-
tion of the Ag(3d) peak was also performed. The binding
energy of the Ag(3d5/2) core level for Ag, Ag2O, and AgO
is 368.5, 368.3, and 367.7 eV, respectively. Based on the Ag(3d5/2) peak analysis, we have found that about 93% of
the silver atoms on the surface were in the Ag0 (metallic)
state, while only about 1% and 6% of the silver atoms were
in the Ag+ and Ag2+ chemical states, respectively. These
values are in good agreement with published values for
AgNPs.
Particle size distribution analysis of AgNPs
TEM images are captured under high vacuum condi-
tions with a dry sample; before analysis of AgNPs using
Figure 4 XPS analysis of AgNPs.
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determine particle size in aqueous solutions using DLS.
The characterization of nanoparticles in solution is es-
sential before assessing the in vitro toxicity [40]. Particle
size, size distribution, particle morphology, particle com-
position, surface area, surface chemistry, and particle re-
activity in solution are important factors in assessing
nanoparticle toxicity [40]. DLS is a valuable technique to
evaluate particle size, and size distribution of nanoma-
terials in solution. In the present study, DLS was used,
in conjunction with TEM, to evaluate the size distribu-
tion of AgNPs. The AgNPs showed with an average size
of 5 nm, which exactly matches with TEM observation
(Figure 5). The DLS pattern revealed that leaf extract-
mediated synthesized AgNPs showed with an average
size of 5 ± 4 nm. Singhal et al. [6] reported that the silver
nanoparticles synthesized using Ocimum sanctum leaf
extract showed an average diameter of 22.38 nm. Recently,
Sathiya and Akilandeswari [26] reported that the particle
size distribution of silver nanoparticles synthesized byFigure 5 Size distribution analysis of AgNPs was determined by dyna
that the average particle size was approximately 5 nm.Delonix elata leaf broth shows that particles are polydis-
perse mixture, with average diameter 70.01 nm.
Size and morphology analysis of AgNPs using TEM
TEM is one of the most valuable tools to directly analyze
structural information of the nanoparticles. TEM was
used to obtain essential information on primary nano-
particle size and morphology [40]. TEM micrographs of
the AgNPs revealed distinct, uniformly spherical shapes
that were well separated from each other. The average
particle size was estimated from measuring more than
200 particles from TEM images, and showed particle
sizes between 2 and 10 nm with an average size of 5 nm
(Figure 6). Shankar et al. [38] reported that the size of
the nanoparticles produced by geranium leaf extract was
from 16 to 40 nm. The nanoparticles obtained from leaf
extracts of Catharanthus roseus showed with an average
size of 27 to 30 nm. Rodríguez-León et al. [41] synthe-
sized two different populations of nanoparticles such as
small in size with an average diameter around 3 to 5 nm
and another one larger in size between 10 to 20 nm using
different concentrations of leaf extract and AgNO3.
Determination of MIC and sublethal concentration of
AgNPs and antibiotics
The MIC (Table 1) and sublethal concentration (Table 2)
of each test strain of bacteria were first determined
against antibiotics and AgNPs alone. The results showed
that the effective doses were different between Gram-
negative and Gram-positive bacteria, with the Gram-
negative P. aeruginosa and S. flexneri found to be more
susceptible to AgNPs. In contrast, AgNPs were compara-
tively less effective against the Gram-positive S. aureus
and S. pneumoniae. This discrepancy could be due to dif-
ferences in the membrane structure and the composition
of the cell wall, thereby affecting access of the AgNPs. Themic light scattering. The particle size distribution analysis revealed
Figure 6 Determination of size and shape of AgNPs. The size and morphology of AgNPs were determined using transmission electron
microscopy. TEM micrograph of AgNPs prepared from A. cobbe (A). The average particle size was found to be 5 nm. Particle size distributions
from TEM images (B).
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teria have an overall negative charge because of the
presence of teichoic acids and lipopolysaccharides, re-
spectively [42]. The potent bactericidal activity of AgNPs
against P. aeruginosa and S. flexneri could be due to
strong interactions between cationic plant compounds
and the negatively charged cell wall components.Figure 7 Effect of AgNPs on cell survival. Dose-dependent effects of Ag
presence of different concentrations of AgNPs. Bacterial survival was determ
SD of three separate experiments each of which contained three replicates
control group by the Student's t test (p < 0.05).Dose-dependent antibacterial effects of AgNPs
The dose-dependent bactericidal activity of AgNPs was
determined using representative Gram-positive and
Gram-negative bacterial strains. Figure 7 shows the tox-
icity of biologically synthesized AgNPs (5.0 nm) at con-
centrations of 0.1 to 0.6 μg/ml to P. aeruginosa, S.
flexneri, S. aureus, and S. pneumoniae. The presence ofNPs on bacterial survival. All test strains were incubated in the
ined at 4 h by a CFU assay. The results are expressed as the means ±
. Treated groups showed statistically significant differences from the
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http://www.nanoscalereslett.com/content/9/1/373AgNPs affected the cell viability of all bacterial strains as
compared to the negative control. Cell viability was re-
duced as the concentrations of the AgNPs increased. For
each bacterial strain, at their respective MIC values, no
growth was observed. Thus, these represent bactericidal
concentrations for each specific bacterial strain. In the
case of P. aeruginosa, 0.6 μg/ml AgNPs caused an
approximately 95% reduction in bacterial density as
compared to the control sample. Increasing the concen-
tration of AgNPs to 0.7 and 1.0 μg/ml caused the
complete absence of bacterial growth as these concen-
trations represent the MIC values. S. flexneri showed
similar trends with P. aeruginosa. Interestingly, for S.
aureus and S. pneumoniae, exposure to a similar con-
centration of AgNPs (i.e., 0.5 μg/ml) caused a reduction
of only about 50% in cell viability as compared to the
control sample. However, as the concentration increased
to 0.75 μg/ml, there was a much greater inhibition of
bacterial growth. The relative order of sensitivity to 5-
nm-sized AgNPs was found to be a function of the strain
of bacteria.
The plant extract-mediated AgNPs exhibited signifi-
cant antimicrobial activity than synthesis of AgNPs from
other sources such as using bacteria and fungi. For ex-
ample, Li et al. [43] reported that 10 μg/mL (AgNPs)
SNPs could completely inhibit the growth of 107 CFUs/
ml of E. coli in liquid MHB. Anthony et al. [44] reported
that the toxicity AgNPs of size 40 nm was evaluated
under non-treated and treated conditions using the cell
viability assay; the results showed that 10 μg/ml treat-
ments of AgNPs decreased the cell viability completely.
Our studies shows that a promising inhibitory effect of
AgNPs against tested strains was observed with lower
concentration of 0.6 μg/ml. Hwang et al. [45] reported
that chemically derived silver nanoparticles in the size
range 10 to 25 nm are effective antimicrobial agents.
Earlier studies show that the interaction stage of Ag
nanoparticles in E. coli and found that at initial stage of
the interaction of AgNPs adhere to bacterial cell wall
subsequently penetrate the bacteria and kill bacterial cell
by destroying cell membrane. AgNPs may pass through
the cell wall of bacteria to oxidize the surface proteins
on the plasma membrane and consequently disturb cel-
lular homeostasis [46,47]. Several research groups sug-
gested that AgNPs may attach to the surface of the cell
membrane and disturb its functions such as permeability
and respiration [47,48]. Our results suggest that AgNPs
synthesized using plant extract seemed to be smaller in
size, which may provide more bactericidal effects than
larger particles, as the cellular uptake of smaller nano-
particles is easier than that of larger particles. Altogether,
our results suggest that A. cobbe leaf extract-mediated
synthesis of AgNPs seems to be smaller in size, which is
having the larger surface area available for interactionwith bacteria and it could provide more bactericidal ef-
fect than the larger particles.
Anti-biofilm activity of AgNPs
AgNPs have been used to inhibit the activity of biofilms.
In the current study, the dose-dependent ability of
AgNPs to inhibit the activity of biofilms formed by the
human pathogens P. aeruginosa, S. flexneri, S. aureus,
and S. pneumoniae was determined under in vitro condi-
tions. All test strains were grown for 24 h in microtiter
plate wells and then treated with concentrations of
AgNPs of 0.1 to 1.0 μg/ml. These results showed that,
for all the tested bacterial strains, the biologically synthe-
sized AgNPs inhibited the activity of biofilms when
compared to the negative control (Figure 8). Interest-
ingly, an inhibition of biofilm activity was observed at
concentrations of AgNPs slightly lower than those that
affected cell viability. Treatment of P. aeruginosa and S.
flexneri for 24 h with 0.5 μg/ml of AgNPs decreased bio-
film activity by more than 90%. Although increasing the
concentrations of AgNPs did not reveal any significant
differences between these two bacteria, treatment of the
Gram-positive bacteria S. aureus and S. pneumoniae
with 0.7 μg/ml of AgNPs decreased biofilm activity by
approximately 90% (Figure 8). Kalishwaralal et al. [23]
reported that anti-biofilm activity of biologically synthe-
sized AgNPs against P. aeruginosa and S. epidermidis
biofilms and found that 100 nM of AgNPs resulted in a
95% to 98% reduction in biofilm formation. Ansari et al.
[49] demonstrated that the colonies were grown without
AgNPs, the organisms appeared as dry crystalline black
colonies, indicating the production of exopolysacchar-
ides, which is the prerequisite for the formation of bio-
film, whereas when the organisms were grown with
AgNPs, the organisms did not survive. Thus, when the
exopolysaccharide synthesis is arrested, the organism
cannot form biofilm [49]. Altogether, our data demon-
strate that, in these bacteria, the activity of biofilms is
more sensitive to AgNPs than is cell death. This suggests
that different signaling mechanisms could be involved in
cell survival and biofilm formation. Chaudhari et al. [50]
reported that AgNPs derived from B. megaterium
showed enhanced quorum quenching activity against S.
aureus biofilm and prevention of biofilm formation, and
they suggested that AgNPs might be involved in neutral-
izing these adhesive substances thus preventing biofilm
formation.
Evaluation of enhanced antibacterial effects when
combining antibiotics and AgNPs
The potential additive or synergistic antibacterial effect
of combining antibiotics with AgNPs was evaluated
using the disc diffusion method. All six antibiotics tested
(ampicillin, chloramphenicol, erythromycin, gentamicin,
Figure 8 Effect of AgNPs on biofilm inhibition. The anti-biofilm activity of AgNPs was assessed by incubating all test strains with different
concentrations of AgNPs for 4 h in a 96-well plate. The results are expressed as the means ± SD of three separate experiments each of which
contained three replicates. Treated groups showed statistically significant differences from the control group by the Student's t test (p < 0.05).
Gurunathan et al. Nanoscale Research Letters 2014, 9:373 Page 11 of 17
http://www.nanoscalereslett.com/content/9/1/373tetracycline, and vancomycin) showed significant (p < 0.05)
antibacterial effects against both Gram-negative and
Gram-positive bacteria (Figure 9). The activities of all the
antibiotics were increased in combination with AgNPs in
all the test bacterial strains. For the Gram-negative bac-
teria P. aeruginosa and S. flexneri, the significant increaseFigure 9 Enhancement of antibacterial activity of antibiotic in the pre
diffusion method. The MICs of AgNPs for each test strain were loaded into
inhibition was determined by measuring the zone of inhibition after 24 h.
antibacterial activity was calculated using the formula (B − A/A) × 100. The r
Treated groups showed statistically significant differences from the controlin activity in combination with AgNPs was observed for
ampicillin (p < 0.05). This was followed by gentamicin,
chloramphenicol, erythromycin, tetracycline, and vanco-
mycin (p < 0.05). In the case of the Gram-positive S.
aureus and S. pneumoniae strains, the order of enhanced
sensitivity was vancomycin, ampicillin, chloramphenicol,sence of AgNPs. Antibacterial activities were determined by the agar
the wells formed on plates containing a bacterial lawn. Growth
Experiments were performed in triplicate. The percentage of enhanced
esults are expressed as the means ± SD of three separate experiments.
group by the Student's t test (p < 0.05).
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0.05). Ampicillin showed the highest percentage of en-
hanced activity against both P. aeruginosa and S. flexneri,
and its activity was enhanced by AgNPs. In Gram-positive
bacteria, the maximum increase in activity against S. aur-
eus and S. pneumoniae was observed with vancomycin.
Interestingly, AgNPs increased the susceptibility of all bac-
terial strains to the antibiotics. These results suggest that
there is differential susceptibility between Gram-negative
and Gram-positive bacteria to the type of antibacterial
agent that is combined with AgNPs. These differences
may relate to the cell wall composition of each strain of
bacteria.
The toxicity of combinations of antibiotics with AgNPs
was assessed by the disc diffusion method. Consistent
with earlier reports [12,51], the combined effect of anti-
biotics with AgNPs was additive. Interestingly, the action
of six different antibiotics (ampicillin, chloramphenicol,
erythromycin, gentamicin, and tetracycline) showed bet-
ter enhanced activity against Gram-negative than against
Gram-positive bacteria in the presence of AgNPs. There
was a significant enhancement seen with ampicillin in P.
aeruginosa and S. flexneri (Figure 9). In contrast, the
maximum increase in activity against S. aureus and S.
pneumoniae was observed with vancomycin. These data
are consistent with earlier reports [12,51,52]. The differ-
ential susceptibility of Gram-negative and Gram-positive
bacteria toward antibacterial agents may depend on dif-
ferences in their cell wall structure [53].
Enhanced antibacterial effects of antibiotics and AgNPs
In vitro killing studies were performed to explore the
possibility of using AgNPs as an antibiotic adjuvant, in-
creasing the effect of both AgNPs and antibiotics were
analysed using sublethal concentrations. In order to
analyze, the bacterial test strains were treated with sub-
lethal concentrations of ampicillin and vancomycin. The
addition of sublethal concentrations of AgNPs to these
antibiotics treatments resulted in significantly enhanced
antimicrobial activity (p < 0.05). Interestingly, both of
these antibiotics showed an enhanced effect with specific
bacteria, compared to control or AgNPs alone. The most
significant effects were observed with ampicillin toward
Gram-negative bacteria (Figure 10A) and with vanco-
mycin toward Gram-positive bacteria (Figure 10B).
Overall, ampicillin displayed significant effects in both
Gram-negative and Gram-positive bacteria [18]. A simi-
lar inhibitory effect was observed on biofilm activity
when these agents were combined. The possibility of
using AgNPs as an antibiotic adjuvant [21] was explored
by assessing their additive or synergistic effects on bac-
terial antibiotic susceptibility. The capacity of silver ions
to potentiate the bactericidal effect of antibiotics was hy-
pothesized to share a common mechanism of actioninvolving the overproduction of ROS [21,54]. The great-
est enhancement by AgNPs was observed with ampicillin
against Gram-negative and vancomycin against Gram-
positive bacteria. These two antibiotics were, therefore,
selected to test the antibacterial and anti-biofilm activity
of combined treatments in Gram-negative and Gram-
positive bacteria. In this experiment, bacteria were incu-
bated with sublethal concentrations of antibiotics or
AgNPs, or combinations of AgNPs and antibiotics, dur-
ing exponential bacterial growth. CFUs were determined
at 24 h after harvesting bacteria at different time points.
The CFU assay showed that sublethal concentrations
of antibiotics or AgNPs alone had a killing effect of ap-
proximately 10% to 15%. However, combinations of anti-
biotics with AgNPs resulted in over an 80% decrease in
CFUs compared to controls (Figure 10A). Ampicillin ex-
hibited a particularly pronounced antibacterial effect
when combined with AgNPs, killing more than 80% of
P. aeruginosa and S. flexneri (p < 0.05). However, this
combination had a much lesser effect on S. aureus and
S. pneumoniae. In response to the combination of
AgNPs with vancomycin, there was a strong killing effect
(p < 0.05) on S. aureus and S. pneumoniae of approxi-
mately 78% (Figure 10B). However, this combination
showed a much smaller effect on P. aeruginosa and S.
flexneri. These results suggest that, irrespective of the
antibiotics, combination treatments resulted in signifi-
cantly higher toxicity (p < 0.05) than in bacterial cells
that were treated with AgNPs or antibiotics alone.
Enhanced anti-biofilm effects of antibiotics and AgNPs
Ampicillin has the potential to act at several different
stages of biofilm activity with different mechanisms of ac-
tion [55]. Morones-Ramirez et al. [21] demonstrated,
using mouse models, that silver and antibiotic combina-
tions, both in vitro and in vivo, have enhanced activity
against bacteria that produce biofilms. To investigate
whether sublethal concentrations of AgNPs in combin-
ation with antibiotics have synergistic effects, bacterial
cells were grown to form biofilms and then treated with
AgNPs alone or in combination with antibiotics. The re-
sults indicated that AgNPs alone inhibited biofilm activity
by approximately 20%. Combinations of AgNPs and ampi-
cillin inhibited biofilm activity in Gram-negative and
Gram-positive bacteria by 70% and 55%, respectively.
Combined treatments with AgNPs and vancomycin inhib-
ited biofilm activity in Gram-negative and Gram-positive
bacteria by 55% and 75%, respectively (Figure 11). Overall,
these data show that combined treatments with AgNPs
and antibiotics enhanced both the inhibition of biofilm ac-
tivity and the levels of cell death. Therefore, combining
AgNPs with different antibiotics at lower concentrations
has the potential to become an effective anti-biofilm and
antibacterial treatment.
Figure 10 Enhanced antibacterial effect of antibiotics in the presence of AgNPs. All test strains were treated for 4 h with sublethal
concentrations of ampicillin or AgNPs, or combinations of AgNPs and ampicillin (A) or combinations of AgNPs and vancomycin (B). All test
strains were treated for 4 h with sublethal concentrations of vancomycin or AgNPs, or combinations of AgNPs and vancomycin. Bacterial survival
was determined at 4 h by the CFU assay. The results are expressed as the means ± SD of three separate experiments, each of which contained
three replicates. Treated groups showed statistically significant differences from the control group by the Student's t test (p < 0.05).
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sistance to various antibacterial agents. Thus, the inhib-
ition of biofilm activity may be important for the
prevention of infections and various other disorders
[23]. The ability of AgNPs to inhibit the activity of bio-
films was assessed against all of the test strains. There
was a concentration-dependent inhibitory effect ofAgNPs on biofilm activity (Figure 11). These results
showed that treatment with 0.5 μg/ml and 0.7 μg/ml of
AgNPs almost completely inhibited the activity of bio-
films in Gram-negative and Gram-positive bacteria, re-
spectively. Overall, our results suggest that biologically
prepared AgNPs not only exhibit potent bactericidal ac-
tivity, but also inhibit the activity of biofilms. Our results
Figure 11 Enhanced biofilm inhibitory activitity of antibiotics and AgNPs. The anti-biofilm activity of AgNPs was assessed by incubating all
test strains with sublethal concentrations of ampicillin or AgNPs, or combinations of AgNPs with the ampicillin antibiotic for 4 h. The results are
expressed as the means ± SD of three separate experiments, each of which contained three replicates. Treated groups showed statistically
significant differences from the control group by the Student's t test (p < 0.05).
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biofilm activity of starch-stabilized nanoparticles in both
Gram-positive and Gram-negative bacteria [7].
AgNPs increases ROS generation in the presence of
antibiotics
The production of ROS, such as hydroxyl radicals, may
be a common mechanism of cell death induced by bac-
tericidal antibiotics [21,54,56,57]. AgNPs induce the for-
mation of ROS in several bacterial and mammalian cell
types [5]. Several studies have reported that ROS areFigure 12 Enhanced effect of antibiotics and AgNPs on ROS generatio
antibiotics or AgNPs, or combinations of AgNPs with antibiotics for 12 h. R
expressed as the means ± SD of three separate experiments, each of which
significant differences from the control group by the Student's t test (p < 0responsible for inducing genetic variability, promoting
or inhibiting cell death, and possibly regulating biofilm
development. The current data suggest that sublethal
concentrations of antibiotics produce a low level of ROS
when compared to AgNPs. The combined treatment of
antibiotic and AgNPs showed a significantly higher pro-
duction of ROS than either agent alone (Figure 12). The
moderate level of ROS generated by AgNPs at subinhibi-
tory concentrations could increase membrane permeabil-
ity and might explain the enhanced activity of ampicillin
and vancomycin seen in the presence of AgNPs. Asn. All test strains were treated with sublethal concentrations of
OS generation was measured by the XTT assay. The results are
contained three replicates. Treated groups showed statistically
.05).
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likely to indirectly affect the interaction of silver with its
targets [21].
Cells were treated with sublethal concentrations of an-
tibiotics alone, or in combination with AgNPs. There
was a notable increase in the levels of ROS following
treatments with AgNPs or antibiotics alone, compared
to the control cells. Interestingly, the combined treat-
ment of AgNPs with ampicillin showed a fourfold in-
crease of ROS generation in Gram-negative bacteria
(Figure 12). A similar effect was also observed with the
combination of AgNPs and vancomycin in Gram-
positive bacteria. However, irrespective of the specific
antibiotic used, the effect of combined treatments on
ROS production was significantly greater than the effect
seen with individual agents at subinhibitory concentra-
tions (p < 0.05).
Earlier studies demonstrated that improved AgNPs
bactericidal activity through silver ion release using
nanocomposites [58-67]. It is generally believed that Ag+
can bind to bacterial cell wall membrane damage it and
so alter its functionality. Ag+ can interact with thiol
groups in proteins, resulting in inactivation of respira-
tory enzymes and leading to the production of reactive
oxygen species [47,48]. Akhavan [58-60] demonstrated
that the main mechanism for silver ion releasing was
inter-diffusion of water and silver nanoparticles through
pores of the TiO2 layer [58]. Akhavan and co-workers
demonstrated improved bactericidal activity of the
Ni/CNTs and the Ni-removed CNTs by adding silver
nanoparticles.
Several studies showed that silver ion release measure-
ments were higher at drying temperature (90°C), which
could provide more diffusion of Ag NPs in the porous
soft matrix to store a considerable amount of AgNPs in
it, resulting in a lasting antibacterial activity [60]. Fur-
ther, several studies reported that excellent silver ion
release in long times through various thin films tech-
nologies [60-67].
The mechanism involved in the enhanced antibacterial
activity of antibiotics with AgNPs may be attributed to
the bonding reaction between nanoparticles and anti-
biotic molecules. The active functional groups of antibi-
otics, such as hydroxyl and amino groups, can react with
the large surface area of the AgNPs by chelation [51].
Morones-Ramirez et al. proposed a mechanism of silver-
induced cell death in which silver may disrupt multiple
bacterial cellular processes, including disulfide bond
formation, metabolism, and iron homeostasis. These
changes may lead to the increased production of ROS
and increased membrane permeability that can potenti-
ate the activity of a broad range of antibiotics against
Gram-negative bacteria in different metabolic states, as
well as to restore antibiotic susceptibility to a resistantbacterial strain. The same mechanism may be at play
when using AgNPs as an adjuvant with antibiotics.
Conclusions
In this work, a systematic methodology was designed to
elucidate the enhanced antibacterial and anti-biofilm ef-
fects of broad-spectrum antibiotics with AgNPs or with-
out AgNPs. To this end, we synthesized AgNPs using an
environmentally friendly approach using supernatant leaf
extract of Allophylus cobbe. Synthesized AgNPs were
then characterized using various analytical techniques.
The synthesized AgNPs particles were uniform in size
with an average size of 5 nm. Furthermore, the antibac-
terial activity of the selected antibiotics was increased in
the presence of AgNPs against test strains. The increase
in activity was more pronounced with ampicillin for
Gram-negative bacteria Pseudomonas aeruginosa and
Shigella flexneri; vancomycin for the Gram-positive bac-
teria Staphylococcus aureus and Streptococcus pneumoniae.
Interestingly, the combination of sublethal concentrations
of antibiotics with AgNPs has significantly increased the
cell death and increased ROS generation than antibiotics
or AgNPs alone. These results could provide a possible
mechanism for the synergistic or enhanced effects of anti-
biotics and AgNPs. These results suggest that AgNPs
could be used as an adjuvant for the treatment of various
infectious diseases caused by Gram-negative and Gram-
positive bacteria. Thus, our findings support the claim that
AgNPs have considerable effective antibacterial activity,
which can be used to enhance the action of existing anti-
biotics against Gram-negative and Gram-positive bacteria.
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